A retrospective study to determine surveillance for cardiac and endocrine late effects in children receiving TKIs in patients with chronic myeloid leukemia and acute lymphoblastic leukemia
Latest Information Update: 26 Aug 2021
At a glance
- Drugs Bosutinib (Primary) ; Dasatinib (Primary) ; Imatinib (Primary) ; Nilotinib (Primary) ; Ponatinib (Primary) ; Protein tyrosine kinase inhibitors
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 26 Aug 2021 New trial record